Return to Article Details
EXPLORING THE DISTRIBUTION OF PRESCRIPTION FOR SULFONYLUREAS IN PATIENTS WITH TYPE 2 DIABETES ACCORDING TO CARDIOVASCULAR RISK FACTORS WITHIN A CANADIAN PRIMARY CARE SETTING
Download
Download PDF